ArticleAnnals of hematology2023

Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy.

Bingjie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.